| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Human Physiology, University of Oregon, Eugene, OR 97403, USA
Recent evidence suggests a role for vasoactive intestinal polypeptide (VIP) in active vasodilatation and it has been shown that VIP-mediated vasodilatation includes a nitric oxide (NO) and histamine component. Thus, the purpose of this study was to determine the role of H1 and H2 histamine receptors and to examine a potential interaction between NO and histamine receptors in cutaneous active vasodilatation. Eleven subjects were instrumented with four microdialysis fibres. Site 1 served as a control and site 2 was perfused with L-NAME to inhibit nitric oxide synthase. Site 3 was perfused with either the H1 antagonist pyrilamine maleate or the H2 antagonist cimetidine. Site 4 was perfused with L-NAME plus pyrilamine maleate or L-NAME plus cimetidine. Laser-Doppler flowmetry (LDF) was used as an index of skin blood flow and cutaneous vascular conductance (CVC) was calculated as LDF/mean arterial pressure and normalized to maximal vasodilatation achieved via 28 mM sodium nitroprusside infusion. During whole body heating, subjects' sublingual temperature increased a minimum of 0.8°C. In the H1 antagonist studies, CVC in L-NAME, pyrilamine, and combined L-NAME plus pyrilamine sites was significantly reduced compared with control (P < 0.001). The L-NAME and combined L-NAME plus pyrilamine sites were significantly reduced compared with pyrilamine only sites (P < 0.05) but no significant differences were observed between sites. In the H2 receptor antagonist studies, CVC in control sites was not significantly different from cimetidine sites. There was no difference between the L-NAME and combined L-NAME plus cimetidine sites but these sites were significantly attenuated compared with control and cimetidine only sites (P < 0.05). These data suggest the rise in skin blood flow during whole body heating contains an H1 histamine receptor component but do not support an H2 histamine receptor component. Furthermore, part of the NO-dependent component of active vasodilatation can be explained by H1 receptor activation.
(Received 12 July 2004;
accepted after revision 15 September 2004;
first published online 16 September 2004)
Corresponding author C. T. Minson: Department of Human Physiology University of Oregon 122 C Esslinger Hall 1240 University of Oregon Eugene, OR 97403-1240, USA. Email: minson{at}oregon.uoregon.edu
This article has been cited by other articles:
|
|
 |
|
  D. L. Kellogg Jr., J. L. Zhao, and Y. Wu Endothelial nitric oxide synthase control mechanisms in the cutaneous vasculature of humans in vivo Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H123 - H129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Kellogg Jr, J. L. Zhao, and Y. Wu Neuronal nitric oxide synthase control mechanisms in the cutaneous vasculature of humans in vivo J. Physiol., February 1, 2008; 586(3): 847 - 857. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lorenzo and C. T. Minson Human cutaneous reactive hyperaemia: role of BKCa channels and sensory nerves J. Physiol., November 15, 2007; 585(1): 295 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Kellogg Jr., G. J. Hodges, C. R. Orozco, T. M. Phillips, J. L. Zhao, and J. M. Johnson Cholinergic mechanisms of cutaneous active vasodilation during heat stress in cystic fibrosis J Appl Physiol, September 1, 2007; 103(3): 963 - 968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. H. Simmons, C. T. Minson, J.-L. Cracowski, and J. R. Halliwill Systemic hypoxia causes cutaneous vasodilation in healthy humans J Appl Physiol, August 1, 2007; 103(2): 608 - 615. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Holowatz and W. L. Kenney Local ascorbate administration augments NO- and non-NO-dependent reflex cutaneous vasodilation in hypertensive humans Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1090 - H1096. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. W. Wilkins, E. A. Martin, S. K. Roberts, and M. J. Joyner Preserved reflex cutaneous vasodilation in cystic fibrosis does not include an enhanced nitric oxide-dependent mechanism J Appl Physiol, June 1, 2007; 102(6): 2301 - 2306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Holowatz and W. L. Kenney Up-regulation of arginase activity contributes to attenuated reflex cutaneous vasodilatation in hypertensive humans J. Physiol., June 1, 2007; 581(2): 863 - 872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Johnson How does skin blood flow get so high? J. Physiol., December 15, 2006; 577(3): 768 - 768. [Full Text] [PDF]
|
|
|
|
|
|
B. J. Wong and C. T. Minson Neurokinin-1 receptor desensitization attenuates cutaneous active vasodilatation in humans J. Physiol., December 15, 2006; 577(3): 1043 - 1051. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Holowatz, C. S. Thompson, and W. L. Kenney Acute ascorbate supplementation alone or combined with arginase inhibition augments reflex cutaneous vasodilation in aged human skin Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2965 - H2970. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. R. McCord, J.-L. Cracowski, and C. T. Minson Prostanoids contribute to cutaneous active vasodilation in humans Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R596 - R602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Holowatz, C. S. Thompson, and W. L. Kenney L-Arginine supplementation or arginase inhibition augments reflex cutaneous vasodilatation in aged human skin J. Physiol., July 15, 2006; 574(2): 573 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Kellogg Jr In vivo mechanisms of cutaneous vasodilation and vasoconstriction in humans during thermoregulatory challenges J Appl Physiol, May 1, 2006; 100(5): 1709 - 1718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Wong, S. J. Williams, and C. T. Minson Minimal role for H1 and H2 histamine receptors in cutaneous thermal hyperemia to local heating in humans J Appl Physiol, February 1, 2006; 100(2): 535 - 540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. McCord, J. M. Beasley, and J. R. Halliwill H2-receptor-mediated vasodilation contributes to postexercise hypotension J Appl Physiol, January 1, 2006; 100(1): 67 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. W. Wilkins, B. J. Wong, N. J. Tublitz, G. R. McCord, and C. T. Minson Vasoactive intestinal peptide fragment VIP10-28 and active vasodilation in human skin J Appl Physiol, December 1, 2005; 99(6): 2294 - 2301. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J Wong, N. J Tublitz, and C. T Minson Neurokinin-1 receptor desensitization to consecutive microdialysis infusions of substance P in human skin J. Physiol., November 1, 2005; 568(3): 1047 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A Holowatz, C. S Thompson, C. T Minson, and W. L. Kenney Mechanisms of acetylcholine-mediated vasodilatation in young and aged human skin J. Physiol., March 15, 2005; 563(3): 965 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M Lockwood, B. W Wilkins, and J. R Halliwill H1 receptor-mediated vasodilatation contributes to postexercise hypotension J. Physiol., March 1, 2005; 563(2): 633 - 642. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
